Tags

Type your tag names separated by a space and hit enter

End of the line for cannabinoid receptor 1 as an anti-obesity target?
Nat Rev Drug Discov. 2008 Dec; 7(12):961-2.NR

Abstract

A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a drug class that was once anticipated to yield blockbusters. Nevertheless, lessons learned might help salvage something for future such approaches.

Authors

No affiliation info available

Pub Type(s)

News

Language

eng

PubMed ID

19043439

Citation

Jones, Dan. "End of the Line for Cannabinoid Receptor 1 as an Anti-obesity Target?" Nature Reviews. Drug Discovery, vol. 7, no. 12, 2008, pp. 961-2.
Jones D. End of the line for cannabinoid receptor 1 as an anti-obesity target? Nat Rev Drug Discov. 2008;7(12):961-2.
Jones, D. (2008). End of the line for cannabinoid receptor 1 as an anti-obesity target? Nature Reviews. Drug Discovery, 7(12), 961-2. https://doi.org/10.1038/nrd2775
Jones D. End of the Line for Cannabinoid Receptor 1 as an Anti-obesity Target. Nat Rev Drug Discov. 2008;7(12):961-2. PubMed PMID: 19043439.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - End of the line for cannabinoid receptor 1 as an anti-obesity target? A1 - Jones,Dan, PY - 2008/12/2/pubmed PY - 2009/1/1/medline PY - 2008/12/2/entrez SP - 961 EP - 2 JF - Nature reviews. Drug discovery JO - Nat Rev Drug Discov VL - 7 IS - 12 N2 - A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a drug class that was once anticipated to yield blockbusters. Nevertheless, lessons learned might help salvage something for future such approaches. SN - 1474-1784 UR - https://www.unboundmedicine.com/medline/citation/19043439/End_of_the_line_for_cannabinoid_receptor_1_as_an_anti_obesity_target L2 - https://doi.org/10.1038/nrd2775 DB - PRIME DP - Unbound Medicine ER -